Prostacare-D

Prostacare-D is a prescription pharmaceutical brand primarily associated with the treatment of Benign Prostatic Hyperplasia (BPH). It is a combination therapy consisting of Tamsulosin Hydrochloride and Dutasteride, designed to improve urine flow and reduce prostate size over time. The product is manufactured and marketed by Chemist Laboratories Ltd., an established pharmaceutical company in Bangladesh.

The brand was developed to serve the local healthcare market in South Asia, following the formulation of widely recognized dual-action prostate medications. While the active ingredients were originally researched by global pharmaceutical giants (such as GSK for Dutasteride), local versions like Prostacare-D are produced independently by domestic laboratories to ensure accessibility and affordability within the regional market. Ownership remains with the founding Bangladeshi company, Chemist Laboratories Ltd., which oversees production and distribution.